Sean F. Scanlan - 12 Sep 2024 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role: Chief Innovation Officer
Signature: /s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan
Issuer symbol: TMCI
Transactions as of: 12 Sep 2024
Net transactions value: +$3,280
Form type: 4
Filing time: 16 Sep 2024, 16:30:05 UTC
Previous filing: 09 Aug 2024
Next filing: 14 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMCI	Common Stock	Options Exercise	$3,280	+33,750	+16%	$0.0972	250,074	12 Sep 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMCI	Stock Option (Right to Buy)	Options Exercise	$0	-33,750	-100%	$0.000000	0	12 Sep 2024	Common Stock	33,750	$0.0972	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 215,185 restricted stock units.
F2	The stock option vested in equal annual installments over 4 years, commencing on December 15, 2014 with the last installment vesting on December 15, 2018.